53 related articles for article (PubMed ID: 24133114)
1. Comparison contrast-enhanced CT with contrast-enhanced US in diagnosing combined hepatocellular-cholangiocarcinoma: a propensity score-matched study.
Yang J; Zhang Y; Bao WY; Chen YD; Jiang H; Huang JY; Zeng KY; Song B; Huang ZX; Lu Q
Insights Imaging; 2024 Feb; 15(1):44. PubMed ID: 38353807
[TBL] [Abstract][Full Text] [Related]
2. Role of Contrast-Enhanced Ultrasound in Evaluation of Cystic Renal Mass.
Das CJ; Agarwal K; Sharma S; Seth A
J Ultrasound Med; 2023 Dec; 42(12):2873-2881. PubMed ID: 37676901
[TBL] [Abstract][Full Text] [Related]
3. An alternative second performance of contrast-enhanced ultrasound for large focal liver lesion is necessary for sufficient characterization.
Wang Y; Wu S
Clin Hemorheol Microcirc; 2023; 84(2):177-184. PubMed ID: 37005881
[TBL] [Abstract][Full Text] [Related]
4. Monitoring after radiofrequency ablation of liver tumors: contrast-enhanced ultrasound (CEUS) vs. contrast-enhanced computer tomography (CECT), two days after procedure.
Korcakova E; Mirka H; Liska V; Hosek P; Bajcurova K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 May; ():. PubMed ID: 29790488
[TBL] [Abstract][Full Text] [Related]
5. Comparative Study on Diagnosis Value of Contrast-Enhanced Ultrasound and Contrast-Enhanced Computed Tomography after Treating Advanced Renal Cancer Patients with Yiqi Jiedu Decoction.
Lan Y; Gong T; Zhou R; Wu M; Liu Z
Evid Based Complement Alternat Med; 2021; 2021():5763618. PubMed ID: 34737777
[TBL] [Abstract][Full Text] [Related]
6. The Value of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Central Lung Cancer with Obstructive Atelectasis.
Safai Zadeh E; Huber KP; Görg C; Prosch H; Findeisen H
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786349
[No Abstract] [Full Text] [Related]
7. Diagnostic Value of SonoVue Contrast-Enhanced Ultrasonography in Nipple Discharge Based on Artificial Intelligence.
Guo L
J Healthc Eng; 2021; 2021():2961697. PubMed ID: 34956565
[TBL] [Abstract][Full Text] [Related]
8. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease.
Lupsor-Platon M; Serban T; Silion AI; Tirpe GR; Tirpe A; Florea M
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672827
[TBL] [Abstract][Full Text] [Related]
9. Bone Fragment Co-transplantation Alongside Bone Marrow Aspirate Infusion Protects Kidney Transplant Recipients.
Luo X; Zhang J; Zou S; Wang X; Chen G; Li Z; Li K; Wang M; Chen Z; Ming C; Zhu X; Gong N
Front Immunol; 2021; 12():630710. PubMed ID: 33643315
[TBL] [Abstract][Full Text] [Related]
10. The Role of Elastography in Non-Alcoholic Fatty Liver Disease.
Constantinescu C; SĂndulescu L; SĂftoiu A
Curr Health Sci J; 2020; 46(3):255-269. PubMed ID: 33304627
[TBL] [Abstract][Full Text] [Related]
11. Multiple liver pseudotumors due to hepatic steatosis and fatty sparing: A non-invasive imaging approach.
Delli Pizzi A; Mastrodicasa D; Sessa B; Cianci R; Caulo M; Basilico R
Eur J Radiol Open; 2019; 6():56-59. PubMed ID: 30671499
[TBL] [Abstract][Full Text] [Related]
12. Detection of liver metastases in cancer patients with geographic fatty infiltration of the liver: the added value of contrast-enhanced sonography.
Bartolotta TV; Taibbi A; Picone D; Anastasi A; Midiri M; Lagalla R
Ultrasonography; 2017 Apr; 36(2):160-169. PubMed ID: 28145108
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the thrombus of abdominal aortic aneurysms using contrast enhanced ultrasound - preliminary results.
Łukasiewicz A; Garkowski A; Rutka K; Janica J; Łebkowska U
Sci Rep; 2016 Sep; 6():34152. PubMed ID: 27677245
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic utility of non-invasive imaging in diabetes management.
Barsanti C; Lenzarini F; Kusmic C
World J Diabetes; 2015 Jun; 6(6):792-806. PubMed ID: 26131322
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.
Hassan K; Bhalla V; El Regal ME; A-Kader HH
World J Gastroenterol; 2014 Sep; 20(34):12082-101. PubMed ID: 25232245
[TBL] [Abstract][Full Text] [Related]
16. Comparison of contrast-enhanced ultrasonography with grey-scale ultrasonography and contrast-enhanced computed tomography in diagnosing focal fatty liver infiltrations and focal fatty sparing.
Janica J; Ustymowicz A; Lukasiewicz A; Panasiuk A; Niemcunowicz-Janica A; Turecka-Kulesza E; Lebkowska U
Adv Med Sci; 2013; 58(2):408-18. PubMed ID: 24133114
[TBL] [Abstract][Full Text] [Related]
17. Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions--a comparison of conventional ultrasound and contrast-enhanced CT.
Fan Z; Li Y; Yan K; Wu W; Yin S; Yang W; Xing B; Li X; Zhang X
Eur J Radiol; 2013 Sep; 82(9):1385-90. PubMed ID: 23727375
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
19. Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice.
Jacob J; Deganello A; Sellars ME; Hadzic N; Sidhu PS
Ultraschall Med; 2013 Dec; 34(6):529-40. PubMed ID: 24132647
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
